Notice: This company has been marked as potentially delisted and may not be actively trading. NeuBase Therapeutics (NBSE) News Today Add Compare Share Share Headlines Stock AnalysisHeadlinesInsider TradesSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Greenlight Capital Q3 2024 LetterOctober 17, 2024 | seekingalpha.comNeuBase Therapeutics shareholder meeting adjourns without dissolution approvalMay 13, 2024 | bizjournals.comNeuBase Therapeutics to delist from Nasdaq next weekMay 6, 2024 | bizjournals.comNeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from NasdaqApril 6, 2024 | finanznachrichten.deNeuBase Therapeutics Announces Receipt of Notice from NasdaqApril 5, 2024 | globenewswire.comWhy Neubase Therapeutics (NBSE) Shares Are NosedivingMarch 27, 2024 | msn.comNeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare moversMarch 26, 2024 | msn.comWhy Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?March 26, 2024 | investorplace.comNeuBase Therapeutics sets shareholder meeting on dissolution planMarch 25, 2024 | bizjournals.comNeuBase Therapeutics IncFebruary 26, 2024 | edition.cnn.comNeuBase Therapeutics, Inc. (NBSE)February 20, 2024 | finance.yahoo.comNeuBase Therapeutics Inc (O7P.BE)January 20, 2024 | ca.finance.yahoo.comCMU halts licensing agreement with NeuBase TherapeuticsDecember 22, 2023 | bizjournals.comTrading was temporarily halted for "NBSE" at 02:11 PM with a stated reason of "LULD pause." Trading set to resume at 02:11 PM. November 30, 2023 | marketbeat.comTrading was temporarily halted for "NBSE" at 01:11 PM with a stated reason of "LULD pause." Trading set to resume at 01:11 PM. November 30, 2023 | marketbeat.comTrading was temporarily halted for "NBSE" at 01:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "NBSE" at 01:11 PM with a stated reason of "LULD pause." Trading set to resume at 01:11 PM. November 30, 2023 | marketbeat.comTrading was temporarily halted for "NBSE" at 10:11 AM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "NBSE" at 10:11 AM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comPsychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNovember 27, 2023 | finance.yahoo.comNeuBase Therapeutics Inc NBSENovember 6, 2023 | morningstar.comNeuBase Therapeutics, Inc. (NBSE.MX)October 6, 2023 | finance.yahoo.comMassive Insider Trade At NeuBase TherapeuticsSeptember 12, 2023 | benzinga.comNeuBase falls after largest shareholder disposes of part stakeSeptember 12, 2023 | msn.comNeuBase Therapeutics Issues Statement Regarding Filing By ShareholderSeptember 8, 2023 | finance.yahoo.comWhy Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?September 6, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: NeuBase Therapeutics (NBSE) and Centessa Pharmaceuticals (CNTA)August 16, 2023 | markets.businessinsider.comNeuBase Therapeutics (NASDAQ: NBSE)August 6, 2023 | fool.comNeuBase Therapeutics to Explore Strategic AlternativesAugust 3, 2023 | finance.yahoo.comPittsburgh biotech firm amends stock incentive planAugust 1, 2023 | bizjournals.comNeuBase Announces Closing of $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq RulesJune 30, 2023 | finance.yahoo.comNeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to RedosingJune 29, 2023 | finance.yahoo.comNeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq RulesJune 28, 2023 | finance.yahoo.comNeuBase Therapeutics, Inc.: NeuBase Announces 1-for-20 Reverse Stock SplitJune 14, 2023 | finanznachrichten.deNeuBase Therapeutics to undertake 1-for-20 reverse share splitJune 14, 2023 | msn.comNeuBase Announces 1-for-20 Reverse Stock SplitJune 14, 2023 | finance.yahoo.comNeuBase to Participate in Jefferies Healthcare ConferenceMay 24, 2023 | finance.yahoo.comNeuBase Releases Promising Preclinical Data From Stealth Editors To Achieve Gene EditingMay 22, 2023 | msn.comNeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors™May 22, 2023 | finance.yahoo.comNeuBase Announces Formation of Gene Editing Advisory BoardMay 16, 2023 | finance.yahoo.comNeuBase Therapeutics, Inc.: NeuBase Reports Business Update and Financial Results for the First Quarter of 2023May 12, 2023 | finanznachrichten.deNeuBase Therapeutics GAAP EPS of -$0.12 misses by $0.02May 11, 2023 | msn.comNeuBase Reports Business Update and Financial Results for the First Quarter of 2023May 11, 2023 | finance.yahoo.comNeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual MeetingMay 2, 2023 | finance.yahoo.comWhy MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving PremarketApril 20, 2023 | msn.comWhy Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving PremarketMarch 27, 2023 | msn.comNeuBase Therapeutics, Inc.: NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023February 15, 2023 | finanznachrichten.deNeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023February 14, 2023 | finance.yahoo.comNeuBase Therapeutics selling stake in company to New York investment firm Alumni CapitalDecember 29, 2022 | finance.yahoo.comNeuBase Therapeutics, Inc.: NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022December 21, 2022 | finanznachrichten.de Get NeuBase Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NBSE and its competitors with MarketBeat's FREE daily newsletter. Email Address ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> NBSE Media Mentions By Week NBSE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBSE News Sentiment▼0.000.60▲Average Medical News Sentiment NBSE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBSE Articles This Week▼00▲NBSE Articles Average Week Get NeuBase Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NBSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HOTH News Today GTBP News Today CANF News Today IMCC News Today ELAB News Today BMRA News Today PPBT News Today AEZS News Today UPXI News Today BNOX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBSE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuBase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuBase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBSE Stock Alerts